Medical science and clinical practice . Past, Present, and Future

Published by NBScience on

Title: Medical science and clinical practice : Past, Present, and Future
Location: Ukraine
Description: Medical science and clinical practice

Past, Present, and Future
Date: 2018-10-20

Questions?

  stem cell therapy in spain barcelona +447778936902 (WhatsApp)

e-mail: head_office@nbscience.com

Categories: medical seminarsoncology conferencesStem Cells therapy

NBScience

contract research organization

0 Comments

Leave a Reply

Your email address will not be published. Required fields are marked *

/

Related Posts

stem cell therapy clinic
ANTI AGING therapies

CRISPR/Cas9 in Treating Monogenic Disorders: A Breakthrough in Sickle Cell Anemia Therapy

CRISPR/Cas9, a revolutionary gene-editing technology, offers new hope for treating monogenic disorders like sickle cell anemia. By precisely targeting and correcting the mutated gene responsible for the disease, CRISPR/Cas9 has the potential to provide a permanent cure, offering significant implications for patients and healthcare systems.

france stem cell therapy
ANTI AGING therapies

Gene Editing with CRISPR/Cas9: Revolutionizing Treatment for Beta-Thalassemia

**CRISPR/Cas9: A Revolutionary Gene Editing Tool for Beta-Thalassemia** CRISPR/Cas9 gene editing technology has emerged as a promising therapeutic approach for beta-thalassemia, a genetic blood disorder. By precisely targeting and modifying the responsible genes, CRISPR/Cas9 offers the potential to correct genetic defects and restore normal hemoglobin production, revolutionizing treatment options for this debilitating condition.

news 2024
ANTI AGING therapies

Targeting Cystic Fibrosis: Advances in CRISPR/Cas9-Mediated Gene Correction

**Excerpt: Cystic Fibrosis Gene Correction Breakthroughs** CRISPR/Cas9 gene editing holds immense promise for treating cystic fibrosis (CF) by correcting the underlying genetic defect. Recent advances have refined gene correction strategies, enhancing efficiency and precision. This article explores the latest developments in CRISPR/Cas9-mediated gene correction for CF, highlighting the potential to restore CFTR function and improve patient outcomes.

stem cell therapy